JP2023526527A5 - - Google Patents
Info
- Publication number
- JP2023526527A5 JP2023526527A5 JP2022571265A JP2022571265A JP2023526527A5 JP 2023526527 A5 JP2023526527 A5 JP 2023526527A5 JP 2022571265 A JP2022571265 A JP 2022571265A JP 2022571265 A JP2022571265 A JP 2022571265A JP 2023526527 A5 JP2023526527 A5 JP 2023526527A5
- Authority
- JP
- Japan
- Prior art keywords
- hsigg
- active portion
- column
- st6gal
- igg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063026875P | 2020-05-19 | 2020-05-19 | |
| US63/026,875 | 2020-05-19 | ||
| PCT/US2021/033156 WO2021236769A1 (en) | 2020-05-19 | 2021-05-19 | Preparation and purification of hypersialylated igg |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023526527A JP2023526527A (ja) | 2023-06-21 |
| JP2023526527A5 true JP2023526527A5 (https=) | 2025-04-09 |
Family
ID=78708028
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022571265A Pending JP2023526527A (ja) | 2020-05-19 | 2021-05-19 | 高シアル化ＩｇＧの調製及び精製 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230193339A1 (https=) |
| EP (1) | EP4153617A4 (https=) |
| JP (1) | JP2023526527A (https=) |
| KR (1) | KR20230012560A (https=) |
| CN (1) | CN115715296A (https=) |
| AU (1) | AU2021275117A1 (https=) |
| BR (1) | BR112022023377A2 (https=) |
| CA (1) | CA3182023A1 (https=) |
| CO (1) | CO2022018364A2 (https=) |
| MX (1) | MX2022014520A (https=) |
| WO (1) | WO2021236769A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112022023334A2 (pt) * | 2020-05-19 | 2022-12-20 | Momenta Pharmaceuticals Inc | Imunoglobulina hipersialilada |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005113604A2 (en) * | 2004-05-14 | 2005-12-01 | Hematech, Llc | Methods for immunoglobulin purification |
| PH12012502193A1 (en) * | 2010-05-06 | 2021-08-09 | Novartis Ag | Compositions and methods of use for therapeutic low density lipoprotein - related protein 6 (lrp6) multivalent antibodies |
| AU2011290672B2 (en) * | 2010-08-20 | 2015-07-09 | Novartis Ag | Antibodies for epidermal growth factor receptor 3 (HER3) |
| EP2877589B1 (en) * | 2012-07-26 | 2024-03-06 | Momenta Pharmaceuticals, Inc. | Glycoproteins with anti-inflammatory properties |
| EP2935610A4 (en) * | 2012-12-20 | 2016-08-31 | Medimmune Llc | METHODS OF USING ION EXCHANGE CHROMATOGRAPHY TO CONTROL GLYCOFORM RATES WITH HIGH MANNOSIS |
| WO2014144621A2 (en) * | 2013-03-15 | 2014-09-18 | Pyranose Biotherapeutics, Inc. | Modified fc fusion proteins |
| CN104327180A (zh) * | 2013-07-23 | 2015-02-04 | 天士力制药集团股份有限公司 | 一种重组人血小板衍生生长因子bb的纯化方法 |
-
2021
- 2021-05-19 KR KR1020227044052A patent/KR20230012560A/ko active Pending
- 2021-05-19 CA CA3182023A patent/CA3182023A1/en active Pending
- 2021-05-19 US US17/926,102 patent/US20230193339A1/en active Pending
- 2021-05-19 WO PCT/US2021/033156 patent/WO2021236769A1/en not_active Ceased
- 2021-05-19 MX MX2022014520A patent/MX2022014520A/es unknown
- 2021-05-19 JP JP2022571265A patent/JP2023526527A/ja active Pending
- 2021-05-19 AU AU2021275117A patent/AU2021275117A1/en active Pending
- 2021-05-19 CN CN202180036183.0A patent/CN115715296A/zh active Pending
- 2021-05-19 BR BR112022023377A patent/BR112022023377A2/pt unknown
- 2021-05-19 EP EP21809739.2A patent/EP4153617A4/en active Pending
-
2022
- 2022-12-17 CO CONC2022/0018364A patent/CO2022018364A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11034754B2 (en) | Method for the purification of antibodies | |
| US9556258B2 (en) | Purification of fusion proteins | |
| JP4826995B2 (ja) | 抗体の変質を防止する精製方法 | |
| JPH0566397B2 (https=) | ||
| HU217850B (hu) | Eljárás antitest tisztítására | |
| JP2011523408A (ja) | 抗体精製方法 | |
| JP2005500265A (ja) | 治療的使用のためのヒト免疫グロブリン濃縮物の調製方法 | |
| CN103596968A (zh) | 用于亲和层析的洗涤溶液和方法 | |
| JP7835691B2 (ja) | 高シアル化免疫グロブリン | |
| JP2020501577A5 (https=) | ||
| JP2022536659A5 (https=) | ||
| JP2020531557A (ja) | タンパク質の精製方法 | |
| JP2023526421A5 (https=) | ||
| JP2023526527A5 (https=) | ||
| US20260062461A1 (en) | Population of antibodies comprising homogeneous antibodies each having left-right asymmetric sugar chains, and method for producing same | |
| CN107964044B (zh) | 从乳样中纯化抗cd20单克隆抗体的方法 | |
| CN120813598A (zh) | 由同源二聚体抗体形成多特异性抗体的方法及包含由此获得的多特异性抗体的药物产品 | |
| CN114292328B (zh) | 一种来源于美洲羊驼中天然抗体的纯化方法及其应用 | |
| JP4249028B2 (ja) | 蛋白質の活性化方法 | |
| US20230193339A1 (en) | Preparation and Purification of Hypersialylated IGG | |
| CA2890339A1 (en) | Method of isolating synagis in the absence of benzonase | |
| CN114539416A (zh) | 一种双特异性抗体的层析纯化工艺 | |
| JP2023511946A (ja) | 精製方法 | |
| RU2844159C1 (ru) | Получение и очистка гиперсиалилированного igg | |
| JP2519561B2 (ja) | 酸性糖タンパク質 |